IP Group PLC — AGM Information 2023

Jun 15, 2023

COMPANIES ACT 2006

PUBLIC COMPANY LIMITED BY SHARES

RESOLUTIONS

OF

IP GROUP PLC

(THE "COMPANY")

At the annual general meeting ("AGM") of the Company held at the offices of the Company at 3 Pancras Square, King's Cross, London, N1C 4AG at 11.00am on 15 June 2023 Resolutions 1 to 14 (inclusive) and 17 were passed as ordinary resolutions and Resolutions 15, 16, 18 and 19 were passed as special resolutions

• 1. To receive the Directors' Report, the Audited Statement of Accounts and Auditor's Report of the Company for the financial year ended 31 December 2022 (the "Annual Report and Accounts").
• To approve the Directors' Remuneration Report for the year ended 31 December 2022. இங்கில் விட்டு விட்ட இருக்கும் இருக்கும் இருக்கும் இருக்கும் இருக்கும் இருக்கும் இருக்கும் இருக்கும் இருக்கும் இருக்கும் இருக்கும் இருக்கும் இருக்கும் இருக்கும் இருக்கும் இ
• 1. December 2022 to be paid on 22 June 2023 to the holders of shares on the register of members at the close of business on 26 May 2023 (the "2022 Final Dividend").
• To re-appoint KPMG LLP as auditor of the Company to hold office from the conclusion of this 4. meeting until the conclusion of the next general meeting of the Company at which accounts are laid before the shareholders in accordance with the provisions of the Act.
• That the Directors be authorised to fix the remuneration of KPMG LLP as auditor of the 5 -Company.
• To elect Ms Anita Kidgell as a Director of the Company. 6.
• To re-elect Mr David Baynes as a Director of the Company. 7.
• To re-elect Dr Caroline Brown as a Director of the Company. 8.
• To re-elect Mr Heejae Chae as Director of the Company. 9.
• 1. To re-elect Sir Douglas Flint as a Director of the Company.
• 1. To re-elect Ms Aedhmar Hynes as a Director of the Company.
• 1. To re-elect Mr Greg Smith as a Director of the Company.
• 1. To re-elect Dr Elaine Sullivan as a Director of the Company.
• 1. That the Directors be and are hereby generally and unconditionally authorised for the purposes of section 551 of the Act to exercise all the powers of the Company to:
  2. (a) allot shares in the Company and to grant rights to subscribe for or to convert any security into such shares in the Company ("Rights") up to an aggregate nominal amount of £6,911,804.32 (being approximately one third of the Company's issued ordinary share capital (excluding treasury shares) as at 19 April 2023, being the latest

practicable date prior to the publication of this notice of meeting the "Latest Practicable Date");and

(b) allot equity securities of the Company (as defined in section 560 of the Act) up to a further aggregate nominal amount of £6,911,804.32 (being approximately one third of the Company's issued share capital excluding treasury shares as at the Latest Practicable Date) in connection with an offer by way of a rights issue,

provided that (i) such authorities shall expire on the earlier of the conclusion of the Company's 2024 Annual General Meeting ("2024 AGM") and 15 September 2024, and (ii) before such expiry the Company may make any offer or agreement which would or might require shares or equity securities to be allotted or Rights to be granted after such expiry and the Directors may allot such shares or equity securities and grant such Rights pursuant to any such offer or agreement as if the authority conferred by this Resolution 14 had not expired. These authorities shall be in substitution for all other authorities granted to the Directors to allot shares or equity securities and grant Rights.

For the purposes of this Resolution 14 and Resolution 15 below, "rights issue" means an offer to ordinary shareholders in proportion (as nearly as may be practicable) to their existing holdings (and, if applicable, to the holders of any other class of equity security in accordance with the rights attached to such class) to subscribe for further securities by means of the issue of a renounceable letter (or other negotiable document) which may be traded for a period before payment for the securities is due, subject to such exclusions or other arrangements as the Directors may deem necessary or expedient in relation to fractions of such securities, the issue, transfer and/ or holding of any securities in certificated fractions or eachificated form, the use of one or more currencies for making payments in respect of such offer, any such shares or other securities being represented by depositary receipts, treasury shares or any legal or practical problems arising under the laws of, or the requirements of any regulatory body or any stock exchange in, any territory.

• 1. That, subject to and conditional on the passing of Resolution 14, the Directors be and are hereby generally empowered pursuant to sections 570 and 573 of the Act to allot equity securities (as defined in section 560 of the Act), payment for which is to be wholly in cash as if section 561(1) of the Act did not apply to any such allotment provided that such power shall be limited:
  2. a)
     • to or in connection with any rights issue, open offer or other pre-emptive offer, open for acceptance for a period determined by the Directors, to the holders of ordinary shares on the register on any fixed record date in proportion (as nearly as may be practicable) to their holdings of ordinary shares (and, if applicable, to the holders of any other class of equity security in accordance with the rights attached to such class), subject to such exclusions or other arrangements as the Directors may deem necessary or expedient in relation to fractions of such securities, the issue, transfer and/or holding of any securities in certificated form or in uncertificated form, the use of one or more currencies for making payments in respect of such offer, any such shares or other securities being represented by depositary receipts, treasury shares or any legal or practical problems arising under the laws of, or the requirements of any regulatory body or any stock exchange in, any territory;
     • to the allotment of equity securities (other than pursuant to paragraph (a)(i) of (ii) this Resolution 15) up to an aggregate nominal amount of £2,073,541.30, representing approximately 10% of the nominal value of the issued ordinary share capital (excluding treasury shares) of the Company as at the Latest Practicable Date; and
     • (iii) a(ii) of this Resolution 15) up to an aggregate nominal amount equal to 20% of

any allotment of equity securities or sale of treasury shares from time to time under paragraph (a)(ii) above, such authority to be used only for the purposes of making a follow-on offer which the Board of the Company determines to be of a kind contemplated by paragraph 3 of section 2B of the Statement of Principles on Dis-applying Pre-Emption Rights most recently published by the Pre-Emption Group prior to the date of this notice.

(b) to the allotment of equity securities in connection with a rights issue.

References herein to the allotment of equity securities shall include the sale of treasury shares (within the meaning of section 724 of the Act). The authority given by this Resolution 15 shall (within the mouning of cooking of coolerred on the Directors by Resolution 14 expire save that, before the expiry of this authority, the Company may make any offer or agreement which would or might require equity securities to be allotted, or treasury shares to be sold, after such expiry and the Directors may allot equity securities, or sell any treasury shares, pursuant to any such offer or agreement as if the power conferred hereby had not expired.

• That, subject to and conditional on the passing of Resolution 14, the Directors be and are 16. hereby generally empowered pursuant to sections 570 and 573 of the Act and in addition to nor authority granted under Resolution 15, to allot equity securities (as defined in section 560 affy adthority gramed anavily in cash as if section 561(1) of the Act did not apply to any such allotment provided that such power shall be limited pursuant to the authority conferred on the Directors by Resolution 14:
  • (a) to the allotment of equity securities up to an aggregate nominal amount of £2,073,541.30, te are anting approximately 10% of the nominal value of the issued ordinary share capital (excluding treasury shares) of the Company as at the Latest Practicable Date used only for the purposes of financing (or refinancing, if the authority is to be used within twelve months after the original transaction) a transaction which the Board of the Company determines to be an acquisition or other capital investment of a kind contemplated by the Statement of Principles on Disapplying Pre-Emption Rights most recently published by the Pre-Emption Group prior to the date of this notice; and
  • (b) to the allotment of equity securities (other than pursuant to paragraph (a) of this Resolution 16) up to an aggregate nominal amount equal to 20% of any allotment of equity securities or sale of treasury shares from time to time under paragraph (a) above, such authority to be used only for the purposes of making a follow-on offer which the Board of the Company determines to be of a kind contemplated by paragraph 3 of section 2B of the Statement of Principles on Dis-applying Pre-Emption Rights most recently published by the Pre-Emption Group prior to the date of this notice.
• References herein to the allotment of equity securities shall include the sale of treasury shares 17. (within the meaning of section 724 of the Act). The authority given by this Resolution 16 shall (within the mounting as the authorities conferred on the Directors by Resolution 14 expire save that, before the expiry of this authority, the Company may make any offer or agreement which would or might require equity securities to be allotted, or treasury shares to be sold, after such expiry and the Directors may allot equity securities, or sell treasury shares, pursuant to any such offer or agreement as if the power conferred hereby had not expired. That, in accordance with section 366 of the Act, the Company and all companies that are subsidiaries of the Company at any time during the period for which this Resolution 17 has effect be and are hereby authorised to incur political expenditure (as defined in section 365 of the Act) not exceeding £50,000 in total during the period beginning with the date of this Resolution and ending at the conclusion of the 2024 AGM.

• That the Company generally be authorised for the purposes of section 701 of the Act to 18. make market purchases (as defined in section 693(4) of the Act) of the Company's ordinary shares on such terms and in such manner as the Directors may from time to time determine, provided that:

• (a) the maximum number of ordinary shares hereby authorised to be purchased is 103,677,065 ordinary shares, being approximately 10% of the Company's issued ordinary share capital (excluding treasury shares) as at the Latest Practicable Date;

• (b) the minimum price (exclusive of expenses) that may be paid is 2 pence for each ordinary share being the nominal value thereof;
• (c) the maximum price (exclusive of expenses) which may be paid for such shares for so long as the Company's ordinary shares are listed on the Official List shall be the higher of (i) 5% above the average of the middle market quotations taken from the London Stock Exchange Daily Official List for the 5 business days before the purchase is made; and (ii) the higher of the price of the last independent trade and the highest current independent bid for an ordinary share in the Company on the trading venues where the market purchases by the Company pursuant to the authority conferred by this Resolution 18 will be carried out);
• (d) the authority hereby conferred shall (unless previously renewed or revoked) expire on the earlier of the 2024 AGM and 15 September 2024; and
• (e) the Company may make a contract to purchase its own shares under the authority hereby conferred prior to the expiry of such authority, which will or may be executed wholly or partly after the expiry of such authority; and may make a purchase of its ordinary shares in pursuance of any such contract.
• 1. 14 clear days' notice.

CHAIR

Date: 15 June 2023